No association of the serotonin transporter polymorphisms 5‐HTTLPR and RS25531 with schizophrenia or neurocognition
Year: 2010
Type: article
Abstract: A promoter polymorphism in the serotonin transporter gene has been widely studied in neuropsychiatry. We genotyped the 5-HTTLPR/rs25531 triallelic polymorphism in 728 schizophrenia cases from the CATIE study and 724 control subjects. In a logistic regression with case/control status as dependent variable and 7 ancestry-informative principal components as covariates, the effect of 5-HTTLPR/rs25531 composite genotype was not significant (odds ratio = 1.008, 95% CI 0.868-1.172, P = 0.91). In cases only, 5-HTTLPR/rs25531 was not associated with neurocognition (summary neurocognitive index P = 0.21, working memory P = 0.32) or symptomatology (PANSS positive P = 0.67 and negative symptoms P = 0.46). We were unable to identify association of the triallelic 5-HTTLPR with schizophrenia, neurocognition, or core psychotic symptoms even at levels of significance unadjusted for multiple comparisons.
DOI: 10.1002/ajmg.b.31077
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1121004391, 1/2 A Large-Scale Schizophrenia Association Study in Sweden, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, G4096236044, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, G445903376, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, Molecular Genetics of Schizophrenia, Replication of Schizophrenia Associations in CATIE, G8163728846, CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES, Molecular Genetics of Schizophrenia, G8700482840
OpenAlex ID: W2029064052
